• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Canada

Welcome to the international HTA database


Showing [3283 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2007     Institute for Clinical Evaluative Sciences (ICES) Effectiveness and safety of drug-eluting stents in Ontario
2007     Institute for Clinical Evaluative Sciences (ICES) Quality assessment of administrative data (QuAAD): an opportunity for enhancing Ontario's health data
2007     Institute for Clinical Evaluative Sciences (ICES) The Ontario Wait Time Strategy: no evidence of an adverse impact on other surgeries
2007     Institute for Clinical Evaluative Sciences (ICES) Diagnostic services in Ontario: descriptive analysis and jurisdictional review
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Lubiprostone
2007     Centre Hospitalier de l'Universite de Montreal(CHUM) Sacral nerve stimulation in fecal incontinence
2007     Centre Hospitalier de l'Universite de Montreal(CHUM) Waiting times at CHUM 1: diagnostic imaging, hip and knee replacements,cardiac surgery, cancer care and sight restoration
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Comparative overview of cancer control strategies in selected jurisdictions
2007     Medical Advisory Secretariat (MAS) Scintimammography as an adjunctive breast imaging technology: an evidence-based analysis
2007     Medical Advisory Secretariat (MAS) Multidetector computed tomography for coronary artery disease screening in asymptomatic populations: an evidence-based analysis
2007     Medical Advisory Secretariat (MAS) Anal dysplasia screening: an evidence-based analysis
2007     Medical Advisory Secretariat (MAS) Low-density lipoprotein apheresis: an evidence-based analysis
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [The practice of percutaneous coronary interventions in hospitals without on-site cardiac surgery: review of guidelines and analysis of Quebec data, 1999-2004]
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Population screening for primary open-angle glaucoma
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-acting insulin analogues for diabetes mellitus: meta-analysis of clinical outcomes and assessment of costeffectiveness
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Effectiveness of magnetic resonance imaging (MRI) screening for women at high risk of breast cancer
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Point-of-care monitoring devices for long-term oral anticoagulation therapy: clinical and cost effectiveness
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) The role of hyperbaric oxygen therapy in the management of autism
2007     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. No: 3 fracture management.
2007     Medical Advisory Secretariat (MAS) Systematic review and cost-effectiveness analysis of elective endovascular repair compared to open surgical repair of abdominal aortic aneurysms: Final report
2007     Medical Advisory Secretariat (MAS) Clinical and cost-effectiveness analysis of drug eluting stents compared to bare metal stents for percutaneous coronary interventions in Ontario: final report
2007     Medical Advisory Secretariat (MAS) In-room HEPA cleaners: current and recommended practices
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Capsule colonoscopy: PillCam (TM) colon
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Intra-articular hyaluronic acid (viscosupplementation) for hip osteoarthritis
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Nicotine vaccines for smoking cessation
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Nuchal translucency measurement in first trimester Down Syndrome screening
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacogenomics and warfarin therapy
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Ranolazine (Ranexa (TM)) for chronic stable angina
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Sipuleucel-T (Provenge (TM)): active cellular immunotherapy for advanced prostate cancer
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Subcutaneous open-loop insulin delivery for type 1 diabetes: Paradigm (TM) real-time system
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Yttrium-90 microspheres (TheraSphere (TM) and SIR-Spheres (TM)) for the treatment of unresectable hepatocellular carcinoma
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Extracorporeal shock wave treatment for chronic rotator cuff tendonitis (shoulder pain)
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Extracorporeal shock wave treatment for chronic lateral epicondylitis (tennis elbow)
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Extracorporeal shock wave treatment for chronic plantar fasciitis (heel pain)
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Obstructive sleep apnea: a palatable treatment option?
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Human a1-proteinase inhibitor for patients with a1-antitrypsin deficiency
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Preschool vision screening
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Overview of adjunctive hyperbaric oxygen therapy for diabetic foot ulcer
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Adjunctive hyperbaric oxygen therapy for diabetic foot ulcer: an economic analysis
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Facet joint injection as a diagnostic and therapeutic tool for spinal pain: a review of clinical and cost effectiveness
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Pulsed dye laser therapy for port wine stains
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Triptans for acute migraine: comparative clinical effectiveness and cost-effectiveness
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Effectiveness of neuraminidase inhibitors for prevention of influenza
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Palivizumab prophylaxis against respiratory syncytial virus
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Overview of implantable cardiac defibrillators for primary prevention of sudden cardiac death in high risk patients: clinical efficacy, cost-effectiveness, and psychosocial issues.
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Implantable cardiac defibrillators for primary prevention of sudden cardiac death in high risk patients: a meta-analysis of clinical efficacy, and a review of cost-effectiveness and psychosocial issues
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Clinical and cost-effectiveness of interferon-based therapies for chronic hepatitis C virus infection
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Pegylated interferon combined with ribavirin for chronic hepatitis C virus infection: an economic evaluation
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Overview of long-acting Beta2-agonists (LABA) plus corticosteroids versus LABA alone for chronic obstructive pulmonary disease
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-acting Beta2-agonists (LABA) plus corticosteroids versus LABA alone for chronic obstructive pulmonary disease
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Pancreas transplantation to restore glucose control: review of clinical and economic evidence
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Mobility assistance dogs for mobility-impaired people
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Infliximab and etanercept in rheumatoid arthritis: systematic review of long-term clinical effectiveness, safety, and cost-effectiveness
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Three-wheel and four-wheel scooters: alternatives to powered wheelchairs?
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Infliximab and etanercept in rheumatoid arthritis: timing, dose escalation, and switching
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Viscosupplementation for the treatment of osteoarthritis of the knee
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term clinical and cost-effectiveness of infliximab and etanercept for rheumatoid arthritis
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Grazax: an oral vaccine for the treatment of grass pollen allergy (Hay fever)
2007     Medical Advisory Secretariat (MAS) Optimal health system design for preventive health screening
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable home hemodialysis for kidney failure
2007     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of image-free computer-assisted systems in total knee replacement surgeries
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Human papillomavirus (HPV) vaccines: A Canadian update
2007     Technology Assessment Unit of the McGill University Health Centre (MUHC) Drotrecogin alfa (activated) in severe sepsis
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Maraviroc (Celsentri) for multidrug-resistant human immunodeficiency virus (HIV)-1
2007     Institute of Health Economics (IHE) Evidence of benefit from telemental health applications: a systematic review
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Diagnostic performance of imaging techniques used for the preoperative locoregional staging of rectal cancer: a systematic review
2007     Institute of Health Economics (IHE) The use of videoconferencing for mental health services in Canada and Finland
2007     Technology Assessment Unit of the McGill University Health Centre (MUHC) Pulsatile machine perfusion compared to cold storage in kidney preservation
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting insulin analogues for diabetes mellitus: meta-analysis of clinical outcomes and assessment of cost-effectiveness
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Diagnostic performance and costeffectiveness of technologies to measure bone mineral density in postmenopausal women
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Place of hyperbaric oxygen therapy in the management of cerebral palsy]
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Tandem mass spectrometry and neonatal blood screening in Quebec]
2007     WorkSafeBC Musculoskeletal disorders of the upper extremities. Are they associated with computer work?
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Autologous blood donations]
2006     Medical Advisory Secretariat (MAS) Enhanced external counterpulsation (EECP): an evidence-based analysis
2006     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Management of chronic (non-cancer) pain: organization of health services
2006     Alberta Heritage Foundation for Medical Research (AHFMR) Strategies to reduce emergency department overcrowding
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Non-physicians performing screening flexible sigmoidoscopy: clinical efficacy and cost-effectiveness
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Transdermal hormone replacement therapy patches for women with postmenopausal symptoms: economic analysis of short-term use
2006     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Acticoat (TM) for the treatment of severe burns
2006     Institute of Health Economics (IHE) Gastric electrical stimulation (Enterra therapy system) for the treatment of gastroparesis
2006     Medical Advisory Secretariat (MAS) Optimum methadone compliance testing: an evidence-based analysis
2006     Medical Advisory Secretariat (MAS) Utilization of DXA bone mineral densitometry in Ontario: an evidence-based analysis
2006     Medical Advisory Secretariat (MAS) Routine eye examinations for persons 20-64 years of age: an evidence-based analysis
2006     Alberta Heritage Foundation for Medical Research (AHFMR) USCOM for cardiac output monitoring
2006     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Bone-anchored hearing aids
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Guidelines for the economic evaluation of health technologies: Canada (3rd Edition)
2006     Medical Advisory Secretariat (MAS) Negative pressure wound therapy: an evidence-based analysis
2006     Alberta Heritage Foundation for Medical Research (AHFMR) The triangle of enhancement medicine, disabled people, and the concept of health: a new challenge for HTA, health research, and health policy
2006     Alberta Heritage Foundation for Medical Research (AHFMR) Confocal scanning laser ophthalmoscopy and scanning laser polarimetry for early diagnosis of glaucoma
2006     Medical Advisory Secretariat (MAS) Extracorporeal photopheresis (ECP): an evidence-based analysis
2006     Medical Advisory Secretariat (MAS) Gastric electrical stimulation: an evidence-based analysis
2006     Medical Advisory Secretariat (MAS) Magnetic resonance imaging (MRI) environment safety in Ontario
2006     Institute for Clinical Evaluative Sciences (ICES) Physician services in rural and northern Ontario
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. I: diagnostic imaging, joint replacement, cancer care, sight restoration, cardiac care
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. 2: selected divisions of the departments of medicine and surgery. Supplement to report no 26 "Wait times at the MUHC 1"
2006     Institute for Clinical Evaluative Sciences (ICES) Recommendations for establishing a citizens' council to guide drug policy in Ontario
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccine for herpes zoster
2006     Canadian Agency for Drugs and Technologies in Health (CADTH) Digital mammography: an update
2006     Medical Advisory Secretariat (MAS) Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis